(Q28574741)

31 January 2017

title

Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala (English)

1 reference

31 January 2017

0 references

1

Tammy J. Sajdyk

1 reference

31 January 2017

Douglas A. Schober

2

1 reference

31 January 2017

David L. Smiley

series ordinal

3

1 reference

31 January 2017

Donald R. Gehlert

series ordinal

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Pharmacology, Biochemistry and Behavior

31 January 2017

published in

1 reference

31 January 2017

volume

71

1 reference

31 January 2017

issue

3

1 reference

31 January 2017

page(s)

419–423

1 reference

Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons.

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

A receptor subtype involved in neuropeptide-Y-induced food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Neuropeptide Y produces anxiety via Y2-type receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Regional distribution of Y-receptor subtype mRNAs in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900679-7

7 January 2021

10.1016/S0091-3057(01)00679-7

Identifiers

DOI

0 references

1 reference